SEMGLEE insulin glargine (rDNA) 100 IU/mL, 3 mL solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

semglee insulin glargine (rdna) 100 iu/ml, 3 ml solution for injection injector pen

maxx pharma pty ltd - insulin glargine, quantity: 100 u/ml - injection, solution - excipient ingredients: sodium hydroxide; glycerol; water for injections; hydrochloric acid; metacresol; zinc chloride - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hyperglycaemia.

INSULIN GLARGINE injection, solution الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

insulin glargine injection, solution

a-s medication solutions - insulin glargine (unii: 2zm8cx04rz) (insulin glargine - unii:2zm8cx04rz) - insulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. limitations of use insulin glargine is not recommended for the treatment of diabetic ketoacidosis. insulin glargine is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] - in patients with hypersensitivity to insulin glargine or one of its excipients [see warnings and precautions (5.5)] risk summary published studies with use of insulin glargine during pregnancy have not reported a clear association with insulin glargine and adverse developmental outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . rats and rabbits were exposed to insulin glargine in animal reproduction studies during organogenesis, respectively 50 times and 10 times the human subcutaneous dose of 0.2 units/kg/day. overall, the effects of insulin g

OPTISULIN 100IU/mL insulin glargine (rbe) 10mL solution for injection vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

optisulin 100iu/ml insulin glargine (rbe) 10ml solution for injection vial

sanofi-aventis australia pty ltd - insulin glargine -

INSULIN GLARGINE SOLOSTAR- insulin glargine injection, solution الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

insulin glargine solostar- insulin glargine injection, solution

a-s medication solutions - insulin glargine (unii: 2zm8cx04rz) (insulin glargine - unii:2zm8cx04rz) - insulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. limitations of use insulin glargine is not recommended for the treatment of diabetic ketoacidosis. insulin glargine is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] - in patients with hypersensitivity to insulin glargine or one of its excipients [see warnings and precautions (5.5)] risk summary published studies with use of insulin glargine during pregnancy have not reported a clear association with insulin glargine and adverse developmental outcomes [see data] . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see clinical considerations] . rats and rabbits were exposed to insulin glargine in animal reproduction studies during organogenesis, respectively 50 times and 10 times the human subcutaneous dose of 0.2 units/kg/day. overall, the effects of insulin g

Caninsulin 40 IU/ml Suspension for Injection أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

caninsulin 40 iu/ml suspension for injection

intervet ireland limited - insulin - suspension for injection - 40 international unit(s)/millilitre - insulin (pork) - cats, dogs - hormone

LIXISENATIDE SANOFI TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE WINTHROP TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI lixisenatide 10 mcg (0.05mg/mL) solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 10 mcg (0.05mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE WINTHROP lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

lixisenatide winthrop lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -